Comparison of the clinical response of stereotactic ventrointermedial thalamotomy with anatomical and pathophysiological features of parkinson's disease

  • VI. Tsymbaliuk The SI Romodanov Neurosurgery Institute NAMS of Ukraine
  • A.O. Popov The SI Romodanov Neurosurgery Institute NAMS of Ukraine
Keywords: Parkinson's disease, levodopa-induced dyskinesia, thalamotomy.

Abstract

Objective – to investigate the clinical response in the surgical treatment of Parkinson's disease (PD) with levodopa-induced dyskinesias (LID) by stereotactic ablations in the nucleus ventrointer- medialis of thalamus (Vim).

Materials and methods. We observed 10 PD patients that underwent ventrointermedial thalamotomy (Vim-thalamotomy) for a resistant tremor combined with the initial LID (Group 1). The study also included 8 patients, with LID development in follow-up after Vim-thalamotomy, previously performed for tremor (Group 2).

Results. In group 1 after Vim-thalamotomy, 9 out of 10 patients had an LID control in the contralateral limbs. A similar clinical observation was found in all 8 patients in group 2: while LID manifested on the ipsilateral side of the previously performed Vim-thalamotomy, they did not develop on the contralateral side. Such apparent antidyskinetic effects of our Vim-thalamotomy contradict contemporary knowledge about the anatomical and pathophysiological features of LID.

Conclusions. The presence of antidyskinetic effect of Vim-thalamotomy in patients with PD may indicate involvement in the lesion site of the adjacent nucleus ventrooralis posterior (Vop). The localization of the ablation in the two adjacent Vim/Vop nuclei is possible by localization of the stereotactic target, corresponding to the coordinates of 3 mm behind the midcommissural point and/or with the diagonal trajectory of the electrode with an uninsulated tip of 4 mm in length. Taking into account the positive effect on the tremor-LID symptom complex, Vim/Vop-thalamotomy can be proposed as an operation of choice for patients with an appropriate phenotype of PD.

Downloads

Download data is not yet available.

References

Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov. Disord. 2001;16:448-58. doi: 10.1002/mds.1090

Diederick N, Goetz CG, Stebbins GT et al. Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson’s disease. Neurol. 1992;42:1311-14.

Benabid AL, Pollak P, Gao D et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J. Neurosurg. 1996;84:203-14.

Tasker RR, Munz M, Junn FS et al. Deep brain stimulation and thalamotomy for tremor compared. Acta Neurochir. 1993;68 [Suppl.]:49-53.

Jankovic J, Cardoso F, Grossman RG: Outcome after stereotactic for parkinsonian, essential and other types of tremor. Neurosurg. 1995;37:680-7

Guridi J, Obeso JA, Rodriguez-Oroz MC, Lozano AA, Manrique M. L-dopa-indused dyskinesia and stereotactic surgery for Parkinson’s disease. Neurosurg. 2008 Feb;62(2):311-23; discussion 323-5. doi: 10.1227/01. neu.0000315998.58022.55.

Fox SH, Katzenschlager R, Lim SY et al. Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson’s disease. Mov. Disord. 2011;26, Suppl. 3:S2-S41. doi: 10.1002/mds.23829.

Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in par- ism Relat. Disord. – 2014. – Vol. 20. – P. 969-974.

Narabayashi H, Yokochi F, Nakajima Y. Levodopa-induced dyskinesia and thalamotomy. J. Neurol. Neuro- surg. Psychiatry. 1984;47:831-9.

Ohye C, Maeda T, Narabayashi H. Physiologically defined VIM nucleus. Its special reference to the control of tremor. Appl. Neurophysiol. 1976-1977;39:285-95.

Ohye C, Hirai T, Miyazaki M. Vim thalamotomy for the treatment of various kinds of tremor. Appl. Neuro- physiol.1982;45:275-80.

Page RD, Sambrook MA, Crossman AR. Thalamotomy for the alleviation of levodopa-induced dyskinesia: Experimental studies in the 1-methyl-4phe- nyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience. 1993;55:147-65.

Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW. Pathophysiology of levodopa-induced dyskinesias in Parkinson’s disease: Problems with the current model. Ann. Neurol. 2000;47 [Suppl. 1]:S22-S34. doi: 10.1111/dmcn.12420.

Marras C, Lang A, Krahn M, Tomlinson G, Naglie G. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations. Mov. Disord. 2004;19:22-8.

Hechtner MC, Vogt T, Zöllner Y et al. Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries. Parkinsonism Relat. Disord. 2014;20:969-74. doi: 10.1016/j. Parkreldis

Brodkey J, Tasker RR, Hamani C et al. Tremor cells in the human thalamus: Differences among neurological disorders. J. Neurosurg. 2004;101:43-7.

Published
2017-12-01
How to Cite
Tsymbaliuk, V., & Popov, A. (2017). Comparison of the clinical response of stereotactic ventrointermedial thalamotomy with anatomical and pathophysiological features of parkinson’s disease. Ukrainian Interventional Neuroradiology and Surgery, 22(4), 44-51. https://doi.org/10.26683/2304-9359-2017-4(22)-44-51